SEC Form 4 · accession 0001140361-16-048258
ARDELYX, INC. · ARDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P. Rosenbaum
Officer — SVP, Drug Development
Period of report
Jan 15, 2016
Accepted (ET)
Jan 20, 2016 · 7:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437402
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.55 | Jan 15, 2016 | A | 90,377 | A | — | Jan 15, 2026 | Common Stock | 90,377 | 90,377 | D |
Explanation of responses
- F1The option becomes exercisable as it vests and the shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of January 15, 2016, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.